WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://smart.who.int/hiv/ValueSet/HIV.E.DE264 | Version: 0.3.0 | |||
| Active as of 2024-10-30 | Computable Name: HIVEDE264 | |||
Value set of type of hypertensive disorder of the mother
References
Generated Narrative: ValueSet HIV.E.DE264
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.E.DE265 | Chronic hypertension | Hypertension detected pre-pregnancy or before 20 weeks' gestation |
| HIV.E.DE266 | Essential | Hypertension without a known secondary cause (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE267 | Secondary | Hypertension with a known secondary cause (e.g. renal disease; detected pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE268 | White-coat hypertension | sBP greater than or equal to 140 and/or dBP greater than or equal to 90 mmHg when measured in the office or clinic, and BP less than 135/85 mmHg using HBPM or ABPM readings (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE269 | Masked hypertension | BP that is less than 140/90 mmHg at a clinic/office visit, but greater then or equal to 135/85 mmHg at other times outside the clinic/ office (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE270 | Gestational hypertension | Hypertension arising de novo at greater than or equal to 20 weeks' gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia |
| HIV.E.DE271 | Transient gestational hypertension | Hypertension arising at greater than or equal to 20 weeks' gestation in the clinic, which resolves with repeated BP readings |
| HIV.E.DE272 | Pre-eclampsia | Pre-eclampsia |
| HIV.E.DE273 | Superimposed on chronic hypertension | Among women with chronic hypertension, development of new proteinuria, another maternal organ dysfunction(s), or evidence of uteroplacental dysfunction. |
Generated Narrative: ValueSet
Expansion based on codesystem WHO SMART HIV Concepts CodeSystem v0.3.0 (CodeSystem)
This value set contains 9 concepts
| Code | System | Display | Definition |
| HIV.E.DE265 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Chronic hypertension | Hypertension detected pre-pregnancy or before 20 weeks' gestation |
| HIV.E.DE266 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Essential | Hypertension without a known secondary cause (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE267 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Secondary | Hypertension with a known secondary cause (e.g. renal disease; detected pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE268 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | White-coat hypertension | sBP greater than or equal to 140 and/or dBP greater than or equal to 90 mmHg when measured in the office or clinic, and BP less than 135/85 mmHg using HBPM or ABPM readings (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE269 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Masked hypertension | BP that is less than 140/90 mmHg at a clinic/office visit, but greater then or equal to 135/85 mmHg at other times outside the clinic/ office (pre-pregnancy or at less than 20 weeks) |
| HIV.E.DE270 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Gestational hypertension | Hypertension arising de novo at greater than or equal to 20 weeks' gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia |
| HIV.E.DE271 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Transient gestational hypertension | Hypertension arising at greater than or equal to 20 weeks' gestation in the clinic, which resolves with repeated BP readings |
| HIV.E.DE272 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Pre-eclampsia | Pre-eclampsia |
| HIV.E.DE273 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Superimposed on chronic hypertension | Among women with chronic hypertension, development of new proteinuria, another maternal organ dysfunction(s), or evidence of uteroplacental dysfunction. |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |